Effectiveness and safety of bolus administration of alteplase in massive pulmonary embolism
- 1 December 1992
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 70 (18) , 1477-1480
- https://doi.org/10.1016/0002-9149(92)90302-f
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Chronic major-vessel thromboembolic pulmonary artery obstruction: appearance at angiography.Radiology, 1992
- Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: A European multicenter double-blind trialJournal of the American College of Cardiology, 1992
- Coronary recanalization rate after intravenous bolus of alteplase in acute myocardial infarctionThe American Journal of Cardiology, 1991
- A Randomized Trial of a Single Bolus Dosage Regimen of Recombinant Tissue Plasminogen Activator in Patients with Acute Pulmonary EmbolismChest, 1990
- Comparison of perfusion lung scanning and angiography in the estimation of vascular obstruction in acute pulmonary embolismEuropean Journal of Nuclear Medicine and Molecular Imaging, 1990
- Effectiveness of multiple bolus administration of tissue-type plasminogen activator in acute myocardial infarctionThe American Journal of Cardiology, 1990
- RANDOMISED CONTROLLED TRIAL OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR VERSUS UROKINASE IN THE TREATMENT OF ACUTE PULMONARY EMBOLISMThe Lancet, 1988
- Treatment of canine embolic pulmonary hypertension with recombinant tissue plasminogen activator. Efficacy of dosing regimes.Circulation, 1988
- The thrombolytic and hemorrhagic effects of tissue type plasminogen activator: Influence of dosage regimens in rabritsThrombosis Research, 1985
- Comparison of Streptokinase and Heparin in Treatment of Isolated Acute Massive Pulmonary EmbolismBMJ, 1971